Hi, it’s Aaron Kirchfeld, Pamela Barbaglia, Dinesh Nair and Swetha Gopinath in London, looking at how Europe's biggest buyout ...

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

Sanofi said on Monday it had entered exclusive talks for the sale of a 50% controlling stake in its consumer health business ...

France will take a stake in Sanofi's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on ...

The French government has warned the United States investment company buying the consumer healthcare division of drugmaker ...

The French drugmaker’s sale of a controlling stake in its Opella unit to US financial juggernaut Clayton Dubilier & Rice for ...

Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...

Earlier this month, Sanofi revealed talks were ongoing with CD&R, and has now confirmed the negotiations could result in the ...

Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...

Sanofi and CD&R announce today a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer ...